JP2022531251A5 - - Google Patents
Info
- Publication number
- JP2022531251A5 JP2022531251A5 JP2021564572A JP2021564572A JP2022531251A5 JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5 JP 2021564572 A JP2021564572 A JP 2021564572A JP 2021564572 A JP2021564572 A JP 2021564572A JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- administration
- salt
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840434P | 2019-04-30 | 2019-04-30 | |
| US62/840,434 | 2019-04-30 | ||
| PCT/IB2020/053938 WO2020222108A1 (en) | 2019-04-30 | 2020-04-27 | Inhibitors of human immunodeficiency virus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531251A JP2022531251A (ja) | 2022-07-06 |
| JP2022531251A5 true JP2022531251A5 (https=) | 2023-04-26 |
| JP7545414B2 JP7545414B2 (ja) | 2024-09-04 |
Family
ID=70482731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564572A Active JP7545414B2 (ja) | 2019-04-30 | 2020-04-27 | ヒト免疫不全ウイルス複製阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220211704A1 (https=) |
| EP (1) | EP3962603A1 (https=) |
| JP (1) | JP7545414B2 (https=) |
| WO (1) | WO2020222108A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11541055B2 (en) | 2018-10-24 | 2023-01-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| JP7703538B2 (ja) * | 2019-12-09 | 2025-07-07 | ヴィーブ、ヘルスケア、カンパニー | カボテグラビルを含んでなる医薬組成物 |
| US20250042926A1 (en) | 2023-05-31 | 2025-02-06 | Gilead Sciences, Inc. | Therapeutic compounds for hiv |
| CN121335877A (zh) | 2023-06-15 | 2026-01-13 | Viiv保健英国第五有限公司 | 用于制备化合物的方法和中间体 |
| TW202547514A (zh) | 2024-02-05 | 2025-12-16 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| AU2012278976B2 (en) | 2011-07-06 | 2017-05-11 | Gilead Sciences, Inc. | Compounds for the treatment of HIV |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| US9220710B2 (en) | 2013-01-09 | 2015-12-29 | Gilead Sciences, Inc. | Therapeutic compounds |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| ES2642265T3 (es) | 2013-01-09 | 2017-11-16 | Gilead Sciences, Inc. | Compuestos terapéuticos para el tratamiento de infecciones virales |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| US10202353B2 (en) | 2014-02-28 | 2019-02-12 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| EP3186239B1 (en) | 2014-08-29 | 2018-10-10 | Gilead Sciences, Inc. | Antiretroviral agents |
| CN119462611A (zh) | 2016-08-19 | 2025-02-18 | 吉利德科学公司 | 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物 |
| TW201906834A (zh) * | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| JP7500555B2 (ja) | 2018-10-25 | 2024-06-17 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| JP2022506399A (ja) | 2018-11-05 | 2022-01-17 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
-
2020
- 2020-04-27 US US17/603,634 patent/US20220211704A1/en not_active Abandoned
- 2020-04-27 JP JP2021564572A patent/JP7545414B2/ja active Active
- 2020-04-27 EP EP20723545.8A patent/EP3962603A1/en not_active Withdrawn
- 2020-04-27 WO PCT/IB2020/053938 patent/WO2020222108A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537047A5 (https=) | ||
| JP2022531251A5 (https=) | ||
| JP6628828B2 (ja) | Ｈｉｖを治療するためのトール様受容体の調節因子 | |
| HRP20240501T1 (hr) | Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije | |
| JP2022191257A5 (https=) | ||
| JP2022523726A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| JP2015038149A5 (https=) | ||
| RU2002111657A (ru) | ГЕКСАГИДРОФУРО [2,3-b] ФУРАН-3-ИЛ-N-{3-[(1,3-БЕНЗОДИОКСОЛ-5-ИЛСУЛЬФОНИЛ) (ИЗОБУТИЛ) АМИНО]-1-БЕНЗИЛ-2-ГИДРОКСИПРОПИЛ} КАРБАМАТ КАК ИНГИБИТОР РЕТРОВИРУСНОЙ ПРОТЕАЗЫ | |
| JP2020097577A5 (https=) | ||
| JP2022525013A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2015522630A5 (https=) | ||
| JP2017533972A5 (https=) | ||
| JP2016516773A5 (https=) | ||
| JP2019533660A5 (https=) | ||
| RU2019135261A (ru) | Фармацевтическая композиция, содержащая ингибитор pde9 | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2025508656A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| JP2025520237A5 (ja) | 哺乳動物の非結核性マイコバクテリア感染症治療薬 | |
| JP2023502053A5 (https=) | ||
| JP2022550828A5 (https=) | ||
| RU2011111117A (ru) | Лечение аутоиммунных заболеваний |